Overview

Phloretin is a dihydrochalcone — a subclass of flavonoids — found primarily in the leaves, bark, and fruit skin of apple trees (Malus domestica). Its glycosylated form, phlorizin (phloretin-2'-O-glucoside), was one of the first compounds historically used to induce experimental glycosuria in research, as it inhibits sodium-glucose linked transporters (SGLTs) in the kidneys. Phloretin itself is a potent inhibitor of GLUT2, a facilitative glucose transporter expressed in the intestinal epithelium, hepatocytes, pancreatic beta cells, and renal tubules, giving it the ability to modulate glucose absorption and hepatic glucose handling. This mechanism has drawn attention in metabolic research, though the development of synthetic SGLT2 inhibitors for diabetes treatment has largely superseded phlorizin-derived compounds in clinical practice.

Beyond glucose transport, phloretin demonstrates broad biological activity as a potent antioxidant and anti-inflammatory agent. It scavenges reactive oxygen species, inhibits NF-kB signaling, and suppresses the production of pro-inflammatory cytokines including TNF-alpha, IL-1beta, and IL-6. These properties have been studied in models of UV-induced skin damage, where phloretin protects against photoaging, DNA damage, and melanogenesis. In dermatology, phloretin is incorporated into topical antioxidant formulations, often combined with vitamin C, ferulic acid, and vitamin E to create synergistic photoprotective serums. Its lipophilic nature allows good skin penetration compared to more polar flavonoids.

Emerging research has explored phloretin's anticancer potential, with in vitro studies showing growth-inhibitory effects across multiple cancer cell lines through mechanisms involving apoptosis induction, cell cycle arrest, and inhibition of the PI3K/Akt/mTOR pathway. Phloretin also appears to enhance the efficacy of certain chemotherapeutic agents by inhibiting multidrug resistance proteins. While these findings are primarily preclinical, they underscore the compound's pharmacological versatility. Dietary sources include apples (particularly the skin), apple juice, and apple cider, though concentrations are modest compared to supplemental or topical formulations. Phloretin shares structural and functional similarities with other polyphenolic antioxidants such as quercetin, resveratrol, and fisetin.

Mechanism of Action

Mechanism of Action

Phloretin (2',4',6'-trihydroxy-3-(4-hydroxyphenyl)-propiophenone) is a dihydrochalcone polyphenol primarily found in Malus domestica (apple). Unlike most flavonoids, phloretin has an open C-ring structure that contributes to its unique pharmacological profile, particularly its potent glucose transporter inhibition.

Glucose Transport Inhibition

Phloretin's best-characterized biochemical activity is competitive inhibition of facilitative glucose transporters, particularly GLUT2. The dihydrochalcone scaffold occupies the glucose-binding pocket of GLUT2, preventing glucose translocation across the cell membrane. This is pharmacologically significant in the intestinal epithelium (reducing dietary glucose absorption), hepatocytes (reducing hepatic glucose uptake), and pancreatic beta cells (modulating glucose sensing). Phloretin also inhibits GLUT1, SGLT1, and SGLT2 with lower potency.

Antioxidant Mechanisms

Phloretin's four hydroxyl groups provide robust free radical scavenging capacity through hydrogen atom transfer and single electron transfer mechanisms. The 2',4',6'-trihydroxy pattern on the A-ring is particularly effective at stabilizing phenoxyl radicals. Beyond direct scavenging, phloretin chelates pro-oxidant transition metals (Fe2+ and Cu2+), preventing Fenton chemistry. It also activates the Nrf2/ARE pathway, upregulating phase II detoxification enzymes including heme oxygenase-1 (HO-1), NAD(P)H quinone oxidoreductase 1 (NQO1), and glutathione S-transferases.

Anti-Inflammatory Pathways

Phloretin suppresses inflammation through NF-κB pathway inhibition. By blocking IKKβ activation, it prevents IκBα phosphorylation and degradation, retaining NF-κB in the cytoplasm. This reduces expression of pro-inflammatory mediators and adhesion molecules. Phloretin also inhibits MAPK pathways (p38, JNK, ERK1/2), reducing AP-1-dependent inflammatory gene expression.

Dermatological Applications

In skin biology, phloretin inhibits melanogenesis by downregulating tyrosinase expression, and it reduces UV-induced oxidative damage through its combined antioxidant and anti-inflammatory activities. Its ability to penetrate the stratum corneum makes it effective in topical formulations for photoprotection and hyperpigmentation.

Research

Safety Profile

Safety Profile: Phloretin

Common Side Effects

• Generally well-tolerated in both oral and topical applications at studied doses
• Mild gastrointestinal discomfort including nausea and bloating with oral use
• Skin irritation, redness, or mild burning sensation with topical application (particularly at higher concentrations)
• Contact dermatitis in sensitive individuals
• Mild headache (uncommon)

Serious Adverse Effects

• Allergic reactions in individuals with apple or Rosaceae fruit allergies
• Potential disruption of glucose transport (phloretin is a potent SGLT1/SGLT2 and GLUT2 inhibitor); may cause hypoglycemia in susceptible individuals
• Limited human safety data for oral supplementation at therapeutic doses
• Potential endocrine disruption at very high doses (estrogenic activity reported in vitro)
• Phototoxicity potential when combined with certain topical formulations

Contraindications

• Known allergy to apples, pears, or other Rosaceae family fruits
• Diabetes (particularly those on SGLT2 inhibitors or insulin) without medical supervision due to additive glucose-lowering effects
• Pregnancy and breastfeeding (insufficient safety data; estrogenic activity concern)
• Concurrent use of SGLT2 inhibitor medications (empagliflozin, dapagliflozin, canagliflozin)

Drug Interactions

• SGLT2 inhibitors (empagliflozin, dapagliflozin): Additive glucose-lowering and glycosuric effects; increased risk of hypoglycemia and diabetic ketoacidosis
• Insulin and sulfonylureas: Increased hypoglycemia risk due to glucose transporter inhibition
• Certain antibiotics (beta-lactams): Phloretin may affect renal tubular transport of some drugs
• Topical retinoids: Potential for additive skin irritation when used in skincare combinations
• Estrogen-sensitive medications (tamoxifen): Theoretical concern due to estrogenic activity

Population-Specific Considerations

• Skincare use: Most common application; typically used at 1-2% concentration in serums; well-tolerated topically; often combined with vitamin C and ferulic acid
• Diabetics: Exercise caution; phloretin's glucose transporter inhibition may synergize with diabetes medications
• Oral supplementation: Limited standardized dosing data; apple polyphenol extracts containing phloretin generally dosed at 200-500 mg/day
• Research context: Most safety data from in vitro and animal studies; human clinical data is limited primarily to dermatological applications

Pharmacokinetic Profile